![Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) | Business Wire Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) | Business Wire](https://mms.businesswire.com/media/20210408005322/en/739014/22/teva_RGB_JPEG.jpg)
Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) | Business Wire
![Teva Pharmaceutical Industries Teva Pharmaceuticals Europe B.V. Pharmaceutical industry Company NYSE:TEVA, angle, white png | PNGEgg Teva Pharmaceutical Industries Teva Pharmaceuticals Europe B.V. Pharmaceutical industry Company NYSE:TEVA, angle, white png | PNGEgg](https://e7.pngegg.com/pngimages/122/130/png-clipart-teva-pharmaceutical-industries-teva-pharmaceuticals-europe-b-v-pharmaceutical-industry-company-nyse-teva-others-miscellaneous-angle.png)
Teva Pharmaceutical Industries Teva Pharmaceuticals Europe B.V. Pharmaceutical industry Company NYSE:TEVA, angle, white png | PNGEgg
![Teva Pharmaceutical Industries Teva Pharmaceuticals Europe B.V. Pharmaceutical Industry Company NYSE:TEVA PNG, Clipart, Angle, Area, Teva Pharmaceutical Industries Teva Pharmaceuticals Europe B.V. Pharmaceutical Industry Company NYSE:TEVA PNG, Clipart, Angle, Area,](https://cdn.imgbin.com/25/11/8/imgbin-teva-pharmaceutical-industries-teva-pharmaceuticals-europe-b-v-pharmaceutical-industry-company-nyse-teva-others-AmeeshBUH5ASxcuE4QAhUqLTa.jpg)